M&T Bank
CMPX icon

M&T Bank’s Compass Therapeutics CMPX Stock Holding History

M&T Bank’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.9K Buy
18,198
+3,155
+21% +$9.31K ﹤0.01% 1741
2026
Q1 		$79.6K Buy
15,043
+149
+1% +$860 ﹤0.01% 1655
2025
Q4 		$80K Buy
+14,894
New +$68.8K ﹤0.01% 1636

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

M&T Bank's CMPX Position: Q2 2026 in Review

M&T Bank increased its Compass Therapeutics (CMPX) stake by 21% in Q2 2026, buying an estimated $9.31K and bringing the position to 18,198 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

M&T Bank first reported a position in CMPX in Q4 2025 and has held it in 3 quarters since. The position peaked at $80K in Q4 2025. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • M&T Bank held 18,198 shares of Compass Therapeutics worth $39.9K as of Q2 2026.
  • M&T Bank bought 3,155 Compass Therapeutics shares in Q2 2026, an estimated $9.31K.
  • Compass Therapeutics made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1741 holding.
  • M&T Bank first reported a position in Compass Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • M&T Bank's Compass Therapeutics position peaked at $80K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.